Cargando…
Multimarker approach including CRP, sST2 and GDF‐15 for prognostic stratification in stable heart failure
AIMS: Inflammation and cardiac remodelling are common and synergistic pathways in heart failure (HF). Emerging biomarkers such as soluble suppression of tumorigenicity 2 (sST2) and growth differentiation factor‐15 (GDF‐15), which are linked to inflammation and fibrosis process, have been proposed as...
Autores principales: | Kuster, Nils, Huet, Fabien, Dupuy, Anne‐Marie, Akodad, Mariama, Battistella, Pascal, Agullo, Audrey, Leclercq, Florence, Kalmanovich, Eran, Meilhac, Alexandra, Aguilhon, Sylvain, Cristol, Jean‐Paul, Roubille, Francois |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524044/ https://www.ncbi.nlm.nih.gov/pubmed/32649062 http://dx.doi.org/10.1002/ehf2.12680 |
Ejemplares similares
-
STADE‐HF (sST2 As a help for management of HF): a pilot study
por: Huet, Fabien, et al.
Publicado: (2020) -
Multi-Marker Strategy in Heart Failure: Combination of ST2 and CRP Predicts Poor Outcome
por: Dupuy, Anne Marie, et al.
Publicado: (2016) -
Soluble urokinase-type plasminogen activator receptor strongly predicts global mortality in acute heart failure patients: insight from the STADE-HF registry
por: Huet, Fabien, et al.
Publicado: (2021) -
Management of acute heart failure: Contribution of daily bedside echocardiographic assessment on therapy adjustment with impact measure on the 30-day readmission rate (JECICA)
por: Ricci, Jean-Etienne, et al.
Publicado: (2018) -
Idarucizumab (Praxbind(®)) for dabigatran reversal in patients undergoing heart transplantation: a cohort of ten patients
por: Kalmanovich, Eran, et al.
Publicado: (2021)